https://www.selleckchem.com/pr....oducts/netarsudil-ar
These results suggest that PPCS-CI may be a different clinical entity than TYP-CI. Hence, more research is warranted to determine whether the therapeutic interventions that are effective for TYP-CI can also be used for PPCS-CI populations.Goal-directed aiming movements toward visuo-haptic targets (i.e., seen and handheld targets) are generally more precise than those toward visual only or haptic only targets. This multisensory advantage stems from a continuous inflow of haptic and visual target information during the movemen